Andrea Apolo, MD, of the National Cancer Institute, Bethesda, MD, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Apolo discusses the aims, methods and results of the AMBASSADOR study (NCT03244384) of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma.
